Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2007
Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway
Min Jae Lee, Krishnendu Pal, Takafumi Tasaki, et al.
Research Square
|
January 10, 2024
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe
Hari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 22, 2018
VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells
Ramcharan Singh Angom, Ying Wang, Enfeng Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 5, 2024
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe
Hari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
Oncogene
|
August 14, 2019
BRAF<sup>V600E</sup>-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts
Daofu Feng, Bo Qin, Krishnendu Pal, et al.
Nano Letters
|
October 5, 2011
Reactive oxygen species driven angiogenesis by inorganic nanorods
Chitta Ranjan Patra, Jong-Ho Kim, Kallal Pramanik, et al.
Molecular Pharmaceutics
|
May 18, 2016
Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors
Sujan Kumar Mondal, Sudhakar Jinka, Krishnendu Pal, et al.
Nanoscale
|
October 10, 2017
Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer
Krishnendu Pal, Farah Al-Suraih, Roberto Gonzalez-Rodriguez, et al.
Oncotarget
|
November 22, 2017
Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
Jair Machado Espindola-Netto, Claudia C S Chini, Mariana Tarragó, et al.
Molecular Cancer Therapeutics
|
December 12, 2013
Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer
Krishnendu Pal, Ying Cao, Irina N Gaisina, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Proceedings of the National Academy of Sciences of the United States of America
|
December 29, 2007
Synthetic heterovalent inhibitors targeting recognition E3 components of the N-end rule pathway
Min Jae Lee, Krishnendu Pal, Takafumi Tasaki, et al.
Research Square
|
January 10, 2024
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe
Hari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 22, 2018
VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells
Ramcharan Singh Angom, Ying Wang, Enfeng Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 5, 2024
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe
Hari K Rachamala, Vijay S Madamsetty, Ramcharan S Angom, et al.
Oncogene
|
August 14, 2019
BRAF<sup>V600E</sup>-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts
Daofu Feng, Bo Qin, Krishnendu Pal, et al.
Nano Letters
|
October 5, 2011
Reactive oxygen species driven angiogenesis by inorganic nanorods
Chitta Ranjan Patra, Jong-Ho Kim, Kallal Pramanik, et al.
Molecular Pharmaceutics
|
May 18, 2016
Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors
Sujan Kumar Mondal, Sudhakar Jinka, Krishnendu Pal, et al.
Nanoscale
|
October 10, 2017
Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer
Krishnendu Pal, Farah Al-Suraih, Roberto Gonzalez-Rodriguez, et al.
Oncotarget
|
November 22, 2017
Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
Jair Machado Espindola-Netto, Claudia C S Chini, Mariana Tarragó, et al.
Molecular Cancer Therapeutics
|
December 12, 2013
Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer
Krishnendu Pal, Ying Cao, Irina N Gaisina, et al.
Page
of 5